Proposal to list medical thermometers and single use instruments supplied by Jackson Allison Medical & Surgical Limited
PHARMAC is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 August 2018, through a provisional agreement with Jackson Allison Medical & Surgical Limited (“Jackson Allison”).
Consultation closes at 4pm on Thursday, 7 June 2018.
Proposal to list medical devices supplied by Intermed Medical Limited
PHARMAC is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 August 2018, through a provisional agreement with Intermed Medical Limited (“Intermed”).
Consultation closes at 4pm on Friday, 1 June 2018.
Proposal to list non-surgical antimicrobial hand hygiene products
PHARMAC is seeking feedback on a proposal to list a range of non-surgical antimicrobial hand hygiene (“Hand Hygiene”) products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2018, through provisional agreements with 3M New Zealand Limited (“3M”) and Schülke New Zealand Limited (“Schülke”).
Consultation closes at 4pm on Friday, 25 May 2018.
Proposal to list Interventional Radiology products
PHARMAC is seeking feedback on a proposal to list ranges of Interventional Radiology Products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2018 through a provisional agreement with Abbott NZ Limited (“Abbott”) and a proposed amendment to the Agreement with Defries Industries New Zealand (“Defries”).
Consultation closes at 4pm on Friday, 18 May 2018.
Proposal to list negative pressure wound therapy products and iodosorb wound care ointment supplied by Smith & Nephew Limited
PHARMAC is seeking feedback on a proposal to list a range of negative pressure wound therapy equipment and consumables (“NPWT Products”) and iodosorb wound care ointment supplied by Smith & Nephew Limited (“Smith & Nephew”) in Part III of Section H of the Pharmaceutical Schedule, effective from 1 July 2018.
Consultation closes at 4pm on Friday 24 May 2018.
Proposal to remove the funding restrictions for candesartan
Following assessment of bids in PHARMAC’s 2017/18 annual Invitation to Tender, PHARMAC is proposing to remove the Special Authority and hospital restrictions that currently apply to all strengths of candesartan.
Consultation closes at 5 pm on Monday 23 April 2018.
Proposal to list mercaptopurine oral suspension
PHARMAC is seeking feedback on a proposal to list mercaptopurine oral solution (Allmercap) 20 mg per ml from 1 June 2018, through a provisional agreement with Link Pharmaceuticals Limited.
Consultation closes at 5 pm on Friday 20 April 2018.
Proposal to list medical devices supplied by Obex Medical Limited
PHARMAC is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 June 2018, through a provisional agreement with Obex Medical Limited (“Obex”)
We propose to list a range of:
- medical thermometers
- single use instruments
- medical devices used in the prevention of venous thromboembolism (“VTE Prevention”)
Consultation closes at 4pm on Wednesday, 18 April 2018.
Proposal to fund aflibercept and rivaroxaban
PHARMAC is seeking feedback on a proposal to list aflibercept (Eylea) and rivaroxaban (Xarelto) through a provisional agreement with Bayer New Zealand Limited. We are also seeking feedback on a proposal to amend the current hospital restrictions for ranibizumab.
Consultation closes at 5 pm on Monday, 16 April 2018.
Proposal to list single use instruments, and orthopaedic implants and associated products
PHARMAC is seeking feedback on a proposal to list a range of single use instruments, and orthopaedic implants and associated products in Section H Part III of the Pharmaceutical Schedule from 1 June 2018 supplied by Downs Distributors New Zealand Limited and Surgico Medical and Surgical Limited.
Consultation closes at 5pm on Tuesday, 17 April 2018.
Proposal to fund denosumab for osteoporosis
PHARMAC is proposing to fund denosumab (Prolia) injections from 1 June 2018 for the treatment of severe, established osteoporosis subject to certain clinical criteria being met.
Consultation closes at 5 pm on Wednesday, 4 April 2018.
Proposal to list single use instruments supplied by Elite Brands Distribution Ltd
PHARMAC is seeking feedback on a proposal to list a range of Single Use Instruments on Section H Part III of the Pharmaceutical Schedule from 1 May 2018 through a provisional agreement with Elite Brands Distribution Ltd (“Elite”).
Consultation closes at 5pm on Friday, 6 April 2018.
Proposal to list Interventional Radiology products
PHARMAC is seeking feedback on a proposal to list a range of Interventional Radiology Products in Part III of Section H of the Pharmaceutical Schedule from 1 May 2018 through a provisional agreement with Culpan Distributors Ltd (“Culpan”).
Consultation closes at 5pm on Friday, 30 March 2018.
Proposal to widen access and change the funded brand of tenofovir disoproxil and entecavir
PHARMAC is delighted to propose the widening of access to tenofovir disoproxil and entecavir, antiviral medicines used for the treatment of hepatitis B and HIV.
Consultation closes at 5 pm on Monday, 26 March 2018.
Proposal to list negative pressure wound therapy and Prontosan woundcare products supplied by Intermed Medical Limited
PHARMAC is seeking feedback on a proposal to list a range of negative pressure wound therapy equipment and consumables (NPWT Products) and Prontosan woundcare products supplied by Intermed Medical Limited (“Intermed”) in Part III of Section H of the Pharmaceutical Schedule from 1 May 2018.
Consultation closes at 4pm on Wednesday, 4 April 2018.
Proposal to list a range of medical devices used in the prevention of venous thromboembolisms (VTE Prevention) supplied by Mӧlnlycke Health Care Pty Limited
PHARMAC is seeking feedback on a proposal to list a range of VTE Prevention products in Part III of Section H of the Pharmaceutical Schedule from 1 May 2018 through a provisional agreement with Mӧlnlycke Health Care Pty Limited (“Mӧlnlycke”).
Consultation closes at 4pm on Wednesday, 28 March 2018.
Sustagen Hospital Formula list price increase and change to part charge
PHARMAC is seeking feedback on a proposal to increase the list price of oral feed powder (Sustagen Hospital Formula) in Section D and Part II of Section H of the Pharmaceutical Schedule from 1 April 2018.
Consultation closes at 5 pm on Tuesday, 6 March 2018.
Changes to the Pharmaceutical Schedule Rules
We’re working to make the Pharmaceutical Schedule Rules easier to find, use and apply. We’d like your feedback about these proposed changes.
The Schedule Rules govern how subsidised medicines should be prescribed and claimed for in the community. They also govern the supply of hospital medicines and medical devices. Over time, as the scope of the Schedule has grown, the rules have also grown. PHARMAC intends to consolidate and restructure the Schedule Rules, but not change their meaning.
Consultation closes at 5pm on Thursday, 29 March 2018.
Proposal to list orthopaedic implants and associated products supplied by Orthomed NZ Limited
PHARMAC is seeking feedback on a proposal to list a range of Orthopaedic Implants and Associated Products supplied by Orthomed NZ Limited (“Orthomed”) in Part III of Section H of the Pharmaceutical Schedule from 1 April 2018.
Consultation closes at 4pm on Friday 2 March 2018.
Proposal to open list montelukast tablets
PHARMAC is seeking feedback on a proposal to widen funded access to montelukast tablets by removing all Special Authority criteria and restrictions applying to montelukast 4 mg, 5 mg, and 10 mg tablets (Apo-Montelukast) in Section B and in Part II of Section H of the Pharmaceutical Schedule, from 1 April 2018.
Consultation closes at 5pm on Tuesday, 27 February 2018.
Newsletters
Device Advice: Your update on PHARMAC’s Hospital Medical Devices programme.
Hospital News: News about getting the best value for what we spend on hospital pharmaceuticals.
Inpharmation: News about PHARMAC's activities and pharmaceutical-related issues.
Inpharmation in Hospitals: Hospital news about PHARMAC's activities and pharmaceutical-related issues.
Te Whaioranga ePānui: A PHARMAC newsletter for people with an interest in Māori health.
